• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

他汀类药物对冠心病患者的多效性和心脏保护作用的认识。

Awareness of Pleiotropic and Cardioprotective Effect of Statins in Patients with Coronary Artery Disease.

机构信息

Department of Cardiology, Mersin University, Faculty of Medicine, Mersin, Turkey.

Department of Cardiology, Mersin City Hospital, Mersin, Turkey.

出版信息

Biomed Res Int. 2018 Jun 7;2018:8961690. doi: 10.1155/2018/8961690. eCollection 2018.

DOI:10.1155/2018/8961690
PMID:29977920
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6011107/
Abstract

BACKGROUND

Statins are commonly used in the secondary prevention of coronary artery disease. Studies have shown that the rate of statin use is low among patients with coronary artery disease. In this study, we aimed to investigate the reasons for poor patient compliance with statin treatment.

METHODS

A total of 504 patients diagnosed with coronary heart disease were included in the study. Patients were asked 5 questions to assess their level of knowledge about statin therapy.

RESULTS

Among the patients not using statins, 42% stated they did not take the medication because their cholesterol was not high or they did not know they should renew their prescription when they ran out and 35% because they were influenced by news reports in the media suggesting that cholesterol-lowering drugs were harmful. When patients who were aware of the pleiotropic/cardioprotective effects of statins were compared with patients who were not, the more knowledgeable patients had lower noncompliance rate and mean LDL-C level and a higher rate of LDL-C level optimization.

CONCLUSION

We found that patients who are aware of the pleiotropic effects of statins were more compliant with treatment. We believe that spending more time explaining and emphasizing the mechanisms of action, reason for prescribing, and necessary treatment duration of drugs that patients must use will result in greater compliance and improve patient care. In this way, patients may be less influenced by misinformation presented by the media.

摘要

背景

他汀类药物常用于冠心病的二级预防。研究表明,冠心病患者他汀类药物的使用率较低。本研究旨在探讨患者他汀类药物治疗依从性差的原因。

方法

共纳入 504 例冠心病患者。通过询问患者 5 个问题来评估其对他汀类药物治疗的认知水平。

结果

未服用他汀类药物的患者中,42%表示未服用药物是因为胆固醇不高或不知道药物用完后需要续方,35%是因为受到媒体报道的降脂药物有害的影响。与不了解他汀类药物多效性/心脏保护作用的患者相比,了解该作用的患者不依从率和 LDL-C 水平更低,LDL-C 水平优化率更高。

结论

我们发现,了解他汀类药物多效性的患者治疗依从性更高。我们认为,花费更多时间解释和强调药物的作用机制、用药理由和必要的治疗持续时间,将提高患者的依从性,改善患者的治疗效果。这样,患者可能会较少受到媒体错误信息的影响。

相似文献

1
Awareness of Pleiotropic and Cardioprotective Effect of Statins in Patients with Coronary Artery Disease.他汀类药物对冠心病患者的多效性和心脏保护作用的认识。
Biomed Res Int. 2018 Jun 7;2018:8961690. doi: 10.1155/2018/8961690. eCollection 2018.
2
Effect of two intensive statin regimens on progression of coronary disease.两种强化他汀类药物治疗方案对冠状动脉疾病进展的影响。
N Engl J Med. 2011 Dec 1;365(22):2078-87. doi: 10.1056/NEJMoa1110874. Epub 2011 Nov 15.
3
Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy.与他汀类单药治疗滴定相比,依折麦布联合辛伐他汀、阿托伐他汀或瑞舒伐他汀治疗时低密度脂蛋白胆固醇(LDL-C)水平的变化及目标达成情况。
Vasc Health Risk Manag. 2013;9:719-27. doi: 10.2147/VHRM.S49840. Epub 2013 Nov 15.
4
Treatment Trends, Effectiveness, and Safety of Statins on Lipid Goal Attainment in Chinese Percutaneous Coronary Intervention Patients: a Multicenter, Retrospective Cohort Study.他汀类药物在中国经皮冠状动脉介入治疗患者中实现血脂目标的治疗趋势、有效性及安全性:一项多中心回顾性队列研究
Clin Ther. 2017 Sep;39(9):1827-1839.e1. doi: 10.1016/j.clinthera.2017.07.042. Epub 2017 Aug 12.
5
Impact of high-dose statins on vitamin D levels and platelet function in patients with coronary artery disease.大剂量他汀类药物对冠心病患者维生素 D 水平及血小板功能的影响。
Thromb Res. 2017 Feb;150:90-95. doi: 10.1016/j.thromres.2016.12.019. Epub 2016 Dec 28.
6
Intensive statin therapy, used alone or in combination with ezetimibe, improves homocysteine level and lipid peroxidation to a similar degree in patients with coronary artery diseases.强化他汀治疗单独使用或与依折麦布联合使用时,在冠状动脉疾病患者中可使同型半胱氨酸水平和脂质过氧化改善至相似程度。
Pharmacol Rep. 2016 Apr;68(2):344-8. doi: 10.1016/j.pharep.2015.08.019. Epub 2015 Sep 28.
7
Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.在常规临床实践中,与其他他汀类药物相比,瑞舒伐他汀治疗的老年患者的低密度脂蛋白胆固醇(LDL-C)水平及LDL-C达标情况。
Am J Geriatr Pharmacother. 2007 Sep;5(3):185-94. doi: 10.1016/j.amjopharm.2007.10.002.
8
High-Intensity Versus Non-High-Intensity Statins in Patients Achieving Low-Density Lipoprotein Cholesterol Goal After Percutaneous Coronary Intervention.经皮冠状动脉介入治疗后 LDL-C 达标患者中高强度与非高强度他汀类药物的比较。
J Am Heart Assoc. 2018 Nov 6;7(21):e009517. doi: 10.1161/JAHA.118.009517.
9
[Effects of statins on coronary artery disease. Review of the recent publications].[他汀类药物对冠状动脉疾病的影响。近期出版物综述]
Przegl Lek. 2003;60(1):27-9.
10
Clinical usefulness of additional treatment with ezetimibe in patients with coronary artery disease on statin therapy. - From the viewpoint of cholesterol metabolism.-.他汀类药物治疗的冠心病患者加用依折麦布治疗的临床效果。——从胆固醇代谢的角度看。——。
Circ J. 2011;75(10):2496-504. doi: 10.1253/circj.cj-11-0391. Epub 2011 Aug 2.

引用本文的文献

1
A Systematic Review Uncovering Modifiable Influences on Statin Adherence.一项揭示对他汀类药物依从性可改变影响因素的系统评价
Patient Prefer Adherence. 2025 Jan 4;19:29-48. doi: 10.2147/PPA.S502645. eCollection 2025.
2
Omega-3 PUFAs' efficacy in the therapy of coronary artery disease combined with anxiety or depression: a meta-analysis.ω-3多不饱和脂肪酸治疗合并焦虑或抑郁的冠状动脉疾病的疗效:一项荟萃分析。
Front Psychiatry. 2024 Jun 24;15:1368007. doi: 10.3389/fpsyt.2024.1368007. eCollection 2024.
3
Early Effects of Atorvastatin on Vitamin D and Parathyroid Hormone Serum Levels Following Acute Myocardial Infarction.

本文引用的文献

1
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR).2016年欧洲心脏病学会/欧洲动脉粥样硬化学会血脂异常管理指南:欧洲心脏病学会(ESC)和欧洲动脉粥样硬化学会(EAS)血脂异常管理工作组编写,欧洲心血管预防与康复协会(EACPR)提供特别贡献。
Atherosclerosis. 2016 Oct;253:281-344. doi: 10.1016/j.atherosclerosis.2016.08.018. Epub 2016 Sep 1.
2
Impact of a public media event on the use of statins in the French population.一场公共媒体活动对法国人群他汀类药物使用情况的影响。
Arch Cardiovasc Dis. 2017 Feb;110(2):91-98. doi: 10.1016/j.acvd.2016.05.002. Epub 2016 Jul 26.
3
阿托伐他汀对急性心肌梗死后维生素D和甲状旁腺激素血清水平的早期影响。
J Res Pharm Pract. 2019 Jan-Mar;8(1):7-12. doi: 10.4103/jrpp.JRPP_18_55.
Favorable effect of optimal lipid-lowering therapy on neointimal tissue characteristics after drug-eluting stent implantation: qualitative optical coherence tomographic analysis.最佳降脂治疗对药物洗脱支架植入术后新生内膜组织特征的有利影响:光学相干断层扫描定性分析
Atherosclerosis. 2015 Oct;242(2):553-9. doi: 10.1016/j.atherosclerosis.2015.08.014. Epub 2015 Aug 12.
4
The role of media on statin adherence.媒体在他汀类药物依从性方面的作用。
Int J Cardiol. 2015 Dec 15;201:139. doi: 10.1016/j.ijcard.2015.07.095. Epub 2015 Jul 30.
5
Cardiovascular disease in Europe 2014: epidemiological update.欧洲 2014 年心血管疾病:流行病学更新。
Eur Heart J. 2014 Nov 7;35(42):2950-9. doi: 10.1093/eurheartj/ehu299. Epub 2014 Aug 19.
6
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.2013年美国心脏病学会/美国心脏协会成人降低动脉粥样硬化性心血管风险的血胆固醇治疗指南:美国心脏病学会/美国心脏协会实践指南工作组报告
Circulation. 2014 Jun 24;129(25 Suppl 2):S1-45. doi: 10.1161/01.cir.0000437738.63853.7a. Epub 2013 Nov 12.
7
Effect of two intensive statin regimens on progression of coronary disease.两种强化他汀类药物治疗方案对冠状动脉疾病进展的影响。
N Engl J Med. 2011 Dec 1;365(22):2078-87. doi: 10.1056/NEJMoa1110874. Epub 2011 Nov 15.
8
[Adherence to statin therapy and LDL cholesterol goal attainment in type 2 diabetics and secondary prevention patients: the role of education and knowledge].[2型糖尿病患者及二级预防患者他汀类药物治疗依从性与低密度脂蛋白胆固醇目标达成情况:教育与知识的作用]
Turk Kardiyol Dern Ars. 2010 Dec;38(8):544-50.
9
Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗严重冠状动脉疾病的比较
N Engl J Med. 2009 Mar 5;360(10):961-72. doi: 10.1056/NEJMoa0804626. Epub 2009 Feb 18.
10
Differences between clinical trial efficacy and real-world effectiveness.临床试验疗效与真实世界有效性之间的差异。
Am J Manag Care. 2006 Nov;12(15 Suppl):S405-11.